Feed KTYCF
KT

Kits Eyecare Ltd. KTYCF · OTC

$11.59 +0.32% (+$0.04)

Summary

50 / 100 · Bulios Score

What speaks for it

  • Revenue grew by 30% a year over the last 3 years.
  • It holds more cash than debt: $27.4M against $5.15M.
  • The share price is below the Bulios Fair Price.
  • Analysts expect revenue to grow by 21% this fiscal year.

What to watch

  • Out of every 100 CAD of revenue, only 2.5 CAD is left as net profit.
  • Earnings per share swing sharply from year to year.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap

Price against the Bulios Fair Price

P/E against the industry (Specialty Retail)

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 110.0 CAD for 1 CAD of yearly profit.

Valuation in detail

Is it growing?

Yes, fast

Revenue (CAD)

Diluted EPS (CAD)

  • Analyst estimate

Revenue grew by 22% a year over 5 years. Over the last 3 years it grew by 30% a year. For the next fiscal year analysts expect revenue to grow by 21%.

Growth in detail

Does it make money?

Reasonably

Where 100 CAD of revenue goes

Net profit, industry median (Specialty Retail) 21 CAD

Out of every 100 CAD of revenue, 2.5 CAD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

It could repay all its debt from a single year of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.